留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

氟康唑类似物的研究进展

许克寒 黄蕾 吴俊琪 戚麟 金永生 俞世冲

许克寒, 黄蕾, 吴俊琪, 戚麟, 金永生, 俞世冲. 氟康唑类似物的研究进展[J]. 药学实践与服务, 2016, 34(2): 110-113,128. doi: 10.3969/j.issn.1006-0111.2016.02.004
引用本文: 许克寒, 黄蕾, 吴俊琪, 戚麟, 金永生, 俞世冲. 氟康唑类似物的研究进展[J]. 药学实践与服务, 2016, 34(2): 110-113,128. doi: 10.3969/j.issn.1006-0111.2016.02.004
XU Kehan, HUANG Lei, WU Junqi, QI Lin, JIN Yongsheng, YU Shichong. Research progress of fluconazole derivatives[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 110-113,128. doi: 10.3969/j.issn.1006-0111.2016.02.004
Citation: XU Kehan, HUANG Lei, WU Junqi, QI Lin, JIN Yongsheng, YU Shichong. Research progress of fluconazole derivatives[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 110-113,128. doi: 10.3969/j.issn.1006-0111.2016.02.004

氟康唑类似物的研究进展

doi: 10.3969/j.issn.1006-0111.2016.02.004
基金项目: 第二军医大学药学院药学实验中心孵化基地重点课题;本科学员创新实践能力孵化基地项目(2015YJ06)

Research progress of fluconazole derivatives

  • 摘要: 氟康唑是第三代三唑类抗真菌药物,具有水溶性好、广谱和低毒等优点,是临床上治疗真菌感染的首选药物。随着氟康唑耐药菌株的不断出现,研制新型氟康唑类似物成为重要的科研课题。通过对氟康唑结构的修饰,获得新型氟康唑类似物,为进一步的新药合成研究提供线索。
  • [1] Sobue S, Tan K, Haug-Pihale G. The effects of hepatic impairment on the pharmacokinetics of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole[J]. Br J Clin Pharmacol, 2005,59(2):160-166.
    [2] Mora SJ, Cormick MP, Milanesio ME,et al. The photodynamic activity of a novel porphyrin derivative bearing a Fluconazole structure in different media and against Candida albicans[J]. Dyes Pigments, 2010, 87(3):234-240.
    [3] Zhou CH, Yu KG, Meng JP, et al. Dibenzimidazole and oniumcompound thereof, preparation method and medical use thereof:China, 101397276(A)[P].2009.
    [4] Francavilla C, Low E, Nair S, et al. Quaternary ammonium N,N-dichloroamines as topical antimicrobial agents[J]. Bioorg Med Chem Lett, 2009, 19(10):2731-2734.
    [5] Zhou CH, Mi JL, Wu J, et al. Triazole onium compound with antimicrobial activity, preparation method and medical use:China, 101391985(A)[P].2009.
    [6] Zhang YY, Mi JL, Zhou CH, et al. Synthesis of novel fluconazoliums and their evaluation for antibacterial and antifungal activities[J]. Eur J Med Chem, 2011, 46(9):4391-4402.
    [7] Sheng CQ, Zhang WN, Ji HT, et al. Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking[J]. J Med Chem, 2006, 49(8):2512-2525.
    [8] Chai XY, Zhang J, Yu S C, et al. Design,synthesis,and biological evaluation of novel 1-(1H-1,2,4-tri-Azole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols[J]. Bioorg Med Chem Lett, 2009, 19(6):1811-1814.
    [9] Wang WY, Sheng CQ, Che XY, et al. Design, synthesis, and antifungal activity of novel conformationally restricted triazole derivatives[J]. Arch Pharm(Weinheim), 2009, 342(12):732-739.
    [10] Li WH, Zhao L, Tan GG, et al. Enantioseparation of the new antifungal drug iodiconazole and structually related triaditimenol analogues by CE with neutral cyclodextrin additives[J]. Chromatograp-Hia, 2011, 73(8):1009-1014.
    [11] Yu S, Chai X, Hu N, et al. Synthesis and antifungal activity of the novel triazole compounds[J]. Medchemcomm, 2013, 4(4):704-708.
    [12] Yu S, Chai X, Hu H, et al. Synthesis and antifungal evaluation of the novel triazole derivatives as inhibitors of cytochrome P45014a-demethylase[J]. Eur J Med Chem, 2010, 45(3):4435-4445.
    [13] Chai XY, Zhang J, Yu SC, et al. Design,synthesis,and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols[J]. Bioorg Med Chem Lett, 2009, 19(6):1811-1814.
    [14] Giraud F, Loge C, Pagniez F, et al. Design, synthesis, and evaluation of 1-(N-benzylamino)-2-phn-yl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents[J]. Bioorg Med Chem Lett, 2008, 18(6):1820-1824.
    [15] Giraud F, Guillon R, Loge C, et al. Synthesis and structure-activity relationships of 2-phenyl-1-[(pyridinyl-and piperidinylmethyl)amino]-3-(1H-1,2,4-triazol-1-yl) propan-2-ols as antifungal agents[J]. Bioorg Med Chem Lett, 2009, 19(2):301-304.
    [16] Gan LL, Cai JL, Zhou CH. Advances in the research of piperazine compounds as receptor ligands[J]. Chin Pharma J, 2009, 44:1361-1368.
    [17] Gan LL, Lu YH, Zhou CH. Advances in the research of piperazine compounds as enzyme inhibitors[J]. Chin J Biochem Pharm, 2009, 30:127-131.
    [18] Cai JL, Lu YH, Gan LL, et al. Recent advance in the research of piperazine-containing compounds as antimicrobial agents[J]. Chin J Antibiot, 2009, 34:454-462.
    [19] Gan LL, Zhou CH. Synthesis of azole-containing piperazine derivatives and evaluation of their antibacterial, antifungal and cytotoxic activities[J].Bull Korean Chem Soc, 2010, 31(12):3684-3692.
    [20] Na YM. Synthesis and activity of novel 1-halogenobenzylindole linked triazole derivatives as antifungal agents[J]. Bull Korean Chem Soc, 2011, 32(1):307-310.
    [21] Zhao JX, Cao YY, Quan H, et al. In vitro and in vivo activities of HQQ-3, a new triazole antifungal agent[J]. Biol Pharm Bull, 2006, 29(10):2031-2034.
    [22] Xu JM, Cao YB, Zhang J, et al. Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives[J]. Eur J Med Chem, 2011, 46(7):3142-3148.
    [23] Jiang YW, Zhang J, Cao YB, et al. Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents[J]. Bioorg Med Chem Lett, 2011, 21(15):4471-4475.
    [24] Tron GC, Pirali T, Billing RA, et al. Click chemistry reaction in medicinal chemistry:applications of the 1,3-dipolar cycloaddition between azides and alkynes[J].Med Res Rev, 2008, 28(2):278-308.
    [25] WeiJJ, Wang Y, Wang XL, et al. Recent advances of1,2,3-triazole compounds in medicinal chemistry[J]. Chin Pharm J, 2011, 46:481-485.
    [26] Wang BG, Yu SC, Chai XY, et al. Design synthesis and biological evaluation of 3-substituted triazole derivatives[J]. Chin Chem Lett, 2011, 22(5):519-522.
    [27] Fang B, Zhou CH, Rao XC. Synthesis and biological activities of novel amine-derived bis-azoles as potential antibacterial and antifungal agents[J]. Eur J Med Chem, 2010, 45(9):4388-4398.
    [28] Zhou CH, Fang B, Gan LL. Benzyl chloride tertiary amine double azole antimicrobial compounds, preparation and medical use thereof:China, 101323594(B)[P].2011.
    [29] Bendaha H, Yu L, Touzani R, et al. New azole antifungal agents with novel modes of action:synthesis and biological studies of new tridentate ligands based on pyrazole and triazole[J]. Eur J Med Chem, 2011, 46(9):4117-4124.
  • [1] 韩蕾, 仲华, 王欣荣, 王彦.  去甲泽拉木醛的体外抗真菌作用研究 . 药学实践与服务, 2024, 42(4): 151-156. doi: 10.12206/j.issn.2097-2024.202310011
    [2] 张海东, 袁福淼, 张大志, 姜远英, 俞世冲.  含丙基侧链的新型三唑类化合物的设计、合成和抗真菌活性研究 . 药学实践与服务, 2023, 41(2): 86-90. doi: 10.12206/j.issn.2097-2024.202208016
    [3] 王瀚萱, 董家潇, 马颖, 高越, 金永生.  没食子酰哌嗪类化合物的合成及抗真菌作用研究 . 药学实践与服务, 2020, 38(6): 506-508, 542. doi: 10.12206/j.issn.1006-0111.201908127
    [4] 李修政, 赵庆杰, 董家潇, 姜云云, 叶光明.  1位芳基取代的青藤碱衍生物的合成和抗炎活性研究 . 药学实践与服务, 2018, 36(5): 417-421. doi: 10.3969/j.issn.1006-0111.2018.05.007
    [5] 柯学峰, 李京哲, 付奔, 李良景, 柴晓云, 吴秋业.  新型氮唑类化合物的合成及抗真菌活性研究 . 药学实践与服务, 2017, 35(1): 22-25,59. doi: 10.3969/j.issn.1006-0111.2017.01.006
    [6] 庞磊, 赵晶, 倪廷峻弘, 臧成旭, 丁子超, 张大志, 姜远英.  新型含喹啉和噻吩结构的抗真菌化合物的设计与合成 . 药学实践与服务, 2017, 35(1): 17-21,86. doi: 10.3969/j.issn.1006-0111.2017.01.005
    [7] 张治强, 付奔, 王保刚, 张超, 廖万清, 潘炜华, 郭忠武.  含硫的三唑类化合物的合成及抗真菌活性研究 . 药学实践与服务, 2016, 34(4): 334-337. doi: 10.3969/j.issn.1006-0111.2016.04.013
    [8] 吴俊琪, 叶小飞, 黄蕾, 柴晓云, 金永生, 俞世冲.  正交设计法优化新型氮唑类抗真菌化合物关键中间体的合成工艺 . 药学实践与服务, 2016, 34(2): 171-173. doi: 10.3969/j.issn.1006-0111.2016.02.018
    [9] 赵晶, 李冉, 代黎, 蔡瞻, 张大志, 姜远英.  协同氟康唑抗耐药白念珠菌化合物的设计合成及活性研究 . 药学实践与服务, 2016, 34(2): 129-134. doi: 10.3969/j.issn.1006-0111.2016.02.009
    [10] 刘洪川, 金永生, 陈海生.  冬凌草甲素的结构修饰研究进展 . 药学实践与服务, 2016, 34(2): 114-115,134. doi: 10.3969/j.issn.1006-0111.2016.02.005
    [11] 田霖, 郭海霞, 张洁, 焦育强, 吴秋业, 张川.  新型丹参素衍生物的合成与抗心肌缺血活性研究 . 药学实践与服务, 2015, 33(6): 525-528,535. doi: 10.3969/j.issn.1006-0111.2015.06.012
    [12] 任晓慧, 陈新, 刘嘉, 郑灿辉, 任雪琴, 吴兵, 王如锋, 周有骏.  新型三唑二氧戊环类化合物的合成、晶体结构及抗真菌活性 . 药学实践与服务, 2012, 30(5): 344-347. doi: 10.3969/j.issn.1006-0111.2012.05.007
    [13] 王曙东, 陈兴东, 赵庆杰, 邹燕, 胡宏岗, 俞世冲, 汪亭, 柴晓云, 任海祥.  新型三唑醇类化合物的合成及抗真菌活性研究 . 药学实践与服务, 2011, 29(6): 426-430.
    [14] 魏宁, 张松伟, 但志刚, 柴晓云, 俞世冲, 吴秋业.  1-(1H-1,2,4-三唑-1-基)-(2,4-二氟苯基)-3-(N-异丙基-N-取代氨基)-2-丙醇的合成及抗真菌活性 . 药学实践与服务, 2009, 27(5): 324-327,392.
    [15] 章杰兵, 但志刚, 柴晓云, 俞世冲, 古卓良, 周国华.  1-(1H-1,2,4-三唑-1-基)-(2,4-二氟苯基)-3-[N-环丙基-N-(4-取代苄基)]-2-丙醇的合成及抗真菌活性 . 药学实践与服务, 2009, 27(2): 107-110.
    [16] 吴玮峰, 杨志辉, 但志刚, 薛云云, 胡宏岗, 柴晓云, 俞世冲, 吴秋业.  1-(1H-1,2,4-三唑-1-基)-(2,4-二氟苯基)-3-(N-环己基-N-取代氨基)-2-丙醇的合成及抗真菌活性 . 药学实践与服务, 2009, 27(4): 266-269.
    [17] 董环文, 刘超美, 何秋琴, 赵荔华.  斑蝥素及其衍生物的合成及结构修饰的研究进展 . 药学实践与服务, 2008, (2): 97-102.
    [18] 王仁云.  抗真菌药与心血管药物的相互作用 . 药学实践与服务, 2002, (1): 52-55.
    [19] 高武宝, 杜蓉, 李晓东, 刘祖雄.  氟康唑阴道泡腾片的研制和质量标准 . 药学实践与服务, 2001, (5): 282-283.
    [20] 郝俊文, 张海滨, 李香铁, 刘少鸽, 李慎勤.  氟康唑治疗肾移植术后真菌感染 . 药学实践与服务, 1999, (2): 85-87.
  • 加载中
计量
  • 文章访问数:  3613
  • HTML全文浏览量:  580
  • PDF下载量:  25
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-01-04
  • 修回日期:  2015-04-24

氟康唑类似物的研究进展

doi: 10.3969/j.issn.1006-0111.2016.02.004
    基金项目:  第二军医大学药学院药学实验中心孵化基地重点课题;本科学员创新实践能力孵化基地项目(2015YJ06)

摘要: 氟康唑是第三代三唑类抗真菌药物,具有水溶性好、广谱和低毒等优点,是临床上治疗真菌感染的首选药物。随着氟康唑耐药菌株的不断出现,研制新型氟康唑类似物成为重要的科研课题。通过对氟康唑结构的修饰,获得新型氟康唑类似物,为进一步的新药合成研究提供线索。

English Abstract

许克寒, 黄蕾, 吴俊琪, 戚麟, 金永生, 俞世冲. 氟康唑类似物的研究进展[J]. 药学实践与服务, 2016, 34(2): 110-113,128. doi: 10.3969/j.issn.1006-0111.2016.02.004
引用本文: 许克寒, 黄蕾, 吴俊琪, 戚麟, 金永生, 俞世冲. 氟康唑类似物的研究进展[J]. 药学实践与服务, 2016, 34(2): 110-113,128. doi: 10.3969/j.issn.1006-0111.2016.02.004
XU Kehan, HUANG Lei, WU Junqi, QI Lin, JIN Yongsheng, YU Shichong. Research progress of fluconazole derivatives[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 110-113,128. doi: 10.3969/j.issn.1006-0111.2016.02.004
Citation: XU Kehan, HUANG Lei, WU Junqi, QI Lin, JIN Yongsheng, YU Shichong. Research progress of fluconazole derivatives[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 110-113,128. doi: 10.3969/j.issn.1006-0111.2016.02.004
参考文献 (29)

目录

    /

    返回文章
    返回